These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 26458768)

  • 21. Peripheral Blood-Derived Microglia-Like Cells Decrease Amyloid-β Burden and Ameliorate Cognitive Impairment in a Mouse Model of Alzheimer's Disease.
    Kuroda E; Takata K; Nishimura K; Oka H; Sueyoshi M; Aitani M; Kouda A; Satake S; Shima C; Toda Y; Nakata S; Kitamura Y; Ashihara E
    J Alzheimers Dis; 2020; 73(1):413-429. PubMed ID: 31796681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
    Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
    J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease.
    Simard AR; Soulet D; Gowing G; Julien JP; Rivest S
    Neuron; 2006 Feb; 49(4):489-502. PubMed ID: 16476660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microglia receptors and their implications in the response to amyloid β for Alzheimer's disease pathogenesis.
    Doens D; Fernández PL
    J Neuroinflammation; 2014 Mar; 11():48. PubMed ID: 24625061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine.
    Heneka MT; Nadrigny F; Regen T; Martinez-Hernandez A; Dumitrescu-Ozimek L; Terwel D; Jardanhazi-Kurutz D; Walter J; Kirchhoff F; Hanisch UK; Kummer MP
    Proc Natl Acad Sci U S A; 2010 Mar; 107(13):6058-63. PubMed ID: 20231476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IKKβ deficiency in myeloid cells ameliorates Alzheimer's disease-related symptoms and pathology.
    Liu Y; Liu X; Hao W; Decker Y; Schomburg R; Fülöp L; Pasparakis M; Menger MD; Fassbender K
    J Neurosci; 2014 Sep; 34(39):12982-99. PubMed ID: 25253847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
    Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
    Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology.
    Hao W; Liu Y; Liu S; Walter S; Grimm MO; Kiliaan AJ; Penke B; Hartmann T; Rübe CE; Menger MD; Fassbender K
    Brain; 2011 Jan; 134(Pt 1):278-92. PubMed ID: 21115468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abeta peptide immunization restores blood-brain barrier integrity in Alzheimer disease.
    Dickstein DL; Biron KE; Ujiie M; Pfeifer CG; Jeffries AR; Jefferies WA
    FASEB J; 2006 Mar; 20(3):426-33. PubMed ID: 16507760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation, and pathology.
    van Groen T; Miettinen P; Kadish I
    J Alzheimers Dis; 2011; 24(2):301-13. PubMed ID: 21239852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.
    Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE
    Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
    Bi Oh S; Suh N; Kim I; Lee JY
    Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
    Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S
    Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Administrations of human adult ischemia-tolerant mesenchymal stem cells and factors reduce amyloid beta pathology in a mouse model of Alzheimer's disease.
    Harach T; Jammes F; Muller C; Duthilleul N; Cheatham V; Zufferey V; Cheatham D; Lukasheva YA; Lasser T; Bolmont T
    Neurobiol Aging; 2017 Mar; 51():83-96. PubMed ID: 28056358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
    Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
    J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased expression of cathepsin D in monocytes is related to the defective degradation of amyloid-β in Alzheimer's disease.
    Tian L; Zhang K; Tian ZY; Wang T; Shang DS; Li B; Liu DX; Fang WG; Wang ZY; Chen YH
    J Alzheimers Dis; 2014; 42(2):511-20. PubMed ID: 24898658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonviral DNA vaccination augments microglial phagocytosis of beta-amyloid deposits as a major clearance pathway in an Alzheimer disease mouse model.
    Okura Y; Kohyama K; Park IK; Matsumoto Y
    J Neuropathol Exp Neurol; 2008 Nov; 67(11):1063-71. PubMed ID: 18957895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Translational profiling identifies sex-specific metabolic and epigenetic reprogramming of cortical microglia/macrophages in APPPS1-21 mice with an antibiotic-perturbed-microbiome.
    Shaik SM; Cao Y; Gogola JV; Dodiya HB; Zhang X; Boutej H; Han W; Kriz J; Sisodia SS
    Mol Neurodegener; 2023 Dec; 18(1):95. PubMed ID: 38104136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microglia actions in Alzheimer’s disease.
    Prokop S; Miller KR; Heppner FL
    Acta Neuropathol; 2013 Oct; 126(4):461-77. PubMed ID: 24224195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.